Sulcrate Suspension Plus · DIN 02103567 · 1 g/5 mL · Oral suspension
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Sulcrate Suspension Plus · DIN 02103567
Manufacturer: Axcan Pharma Inc.; listing date 1996-10-01
Health Canada: Marketed since 2025-04-23 · brand SULCRATE SUSPENSION PLUS · ATC A02BX02 SUCRALFATE · form Suspension · route Oral · ingredients SUCRALFATE 1 G/5ML · company Abbvie corporation · schedule Prescription
Sulcrate Suspension Plus: Formulary list price $0.14 per unit (the source does not state the unit; exact figure $0.1366). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02103567)
Source record
DIN 02103567: Sulcrate Suspension Plus
Raw flags: sec3=Y
Item: 564000050; group id 698; item number 1724; lccId None; manufacturer id BFI
Source form: Oral Susp; strength: 1g/5mL
Recorded listing: General benefit
Source prices (unrounded): $0.1366; ministry $0.1366
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02103567
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=17852
Shortage status: not checked (no credentials)